Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver and Intrahepatic Biliary Tract Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04172714
What this trial is testing

Low-dose Y90 Treatment Planning for HCC

Who this might be right for
HCCCancer of LiverCancer
Emory University 30
Testing effectiveness (Phase 2)Ended earlyNCT01239355
What this trial is testing

MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous Therapy

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver Carcinoma+1 more
National Cancer Institute (NCI) 15
Not applicableStudy completedNCT01078415
What this trial is testing

Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC)

Who this might be right for
Carcinoma, Hepatocellular
Angiodynamics, Inc. 26
Large-scale testing (Phase 3)UnknownNCT01324076
What this trial is testing

Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver Cancer
University College, London 412
Not applicableUnknownNCT01813942
What this trial is testing

Platform for Medical Information Extraction From Incomplete Data

Who this might be right for
Liver Cancer
National Taiwan University Hospital 10,000
Testing effectiveness (Phase 2)UnknownNCT00003296
What this trial is testing

Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Brown University 26
Not applicableStudy completedNCT04069468
What this trial is testing

Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Boston Scientific Corporation 1,247
Not applicableStudy completedNCT03630068
What this trial is testing

Computer-assisted Tumor Ablation for Patients With Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Insel Gruppe AG, University Hospital Bern 87
Very early researchStudy completedNCT04310540
What this trial is testing

PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Mayo Clinic 42
Not applicableUnknownNCT03766776
What this trial is testing

Anlotinib in the Treatment of Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Cancer of Liver
The First Affiliated Hospital with Nanjing Medical University 40
Testing effectiveness (Phase 2)Ended earlyNCT00422877
What this trial is testing

Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract

Who this might be right for
Cancer of the Liver
American Regent, Inc. 13
Not applicableStudy completedNCT01749332
What this trial is testing

A Pilot Study of Perihepatic Phlebotomy During Hepatic Resections

Who this might be right for
Liver Cancer
Memorial Sloan Kettering Cancer Center 117
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Early research (Phase 1)Study completedNCT00066404
What this trial is testing

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

Who this might be right for
Cancer
Abramson Cancer Center at Penn Medicine
Not applicableLooking for participantsNCT07820644
What this trial is testing

A Cohort Study (Risk Prediction of HCC in Patients With Chronic Liver Disease)

Who this might be right for
Liver Cancer (Primary and Metastatic)
Cai Qingxian 15,000
Not applicableEnrolling By InvitationNCT06061328
What this trial is testing

Project OASIS: Optimizing Approaches to Select Implementation Strategies

Who this might be right for
CirrhosisHepatocellular Carcinoma
VA Office of Research and Development 8,020
Testing effectiveness (Phase 2)Study completedNCT01075399
What this trial is testing

Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors

Who this might be right for
Head and Neck CancerLung CancerLiver Cancer+2 more
Siemens Molecular Imaging 50
Not applicableActive Not RecruitingNCT07298538
What this trial is testing

Long-Term Survival With Lenvatinib-Based Therapy in Unresectable Liver Cancer

Who this might be right for
Unresectable Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 800
Not applicableStudy completedNCT02465892
What this trial is testing

Pillars4Life Trial

Who this might be right for
Breast CancerLung CancerEsophageal Cancer+9 more
Duke University 284
Testing effectiveness (Phase 2)Active Not RecruitingNCT04941287
What this trial is testing

Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer

Who this might be right for
Metastatic Distal Bile Duct AdenocarcinomaMetastatic Gallbladder CarcinomaMetastatic Intrahepatic Cholangiocarcinoma+7 more
National Cancer Institute (NCI) 57
Next Page